BRIEF-Starlake Bioscience returns to profit, to scrap delisting risk warning

March 30 (Reuters) - Starlake Bioscience Co Inc Zhaoqing

Guangdong

* Says it returns to net profit of 24.3 million yuan ($3.53

million) in 2016 versus net loss of 422.4 million yuan year ago

* Says it applies to Shanghai stock exchange to relist its

bonds

* Says it applies to Shanghai stock exchange to cancel

delisting risk warning

Source text in Chinese: http://bit.ly/2oet7nG;

http://bit.ly/2nP8oGl; http://bit.ly/2ochs8s

Further company coverage:

($1 = 6.8880 Chinese yuan renminbi)

(Reporting by Hong Kong newsroom)